APA

Thompson A. M., Johnson A., Quinlan P., Hillman G., Fontecha M., Bray S. E., Purdie C. A., Jordan L. B., Ferraldeschi R., Latif A., Hadfield K. D., Clarke R. B., Ashcroft L., Evans D. G., Howell A., Nikoloff M., Lawrence J. & Newman W. G. (20110321). Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. : Breast cancer research and treatment.

Chicago

Thompson Alastair M, Johnson Andrea, Quinlan Philip, Hillman Grantland, Fontecha Marcel, Bray Susan E, Purdie Colin A, Jordan Lee B, Ferraldeschi Roberta, Latif Ayshe, Hadfield Kirsten D, Clarke Robert B, Ashcroft Linda, Evans D Gareth, Howell Anthony, Nikoloff Michele, Lawrence Jeffrey and Newman William G. 20110321. Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. : Breast cancer research and treatment.

Harvard

Thompson A. M., Johnson A., Quinlan P., Hillman G., Fontecha M., Bray S. E., Purdie C. A., Jordan L. B., Ferraldeschi R., Latif A., Hadfield K. D., Clarke R. B., Ashcroft L., Evans D. G., Howell A., Nikoloff M., Lawrence J. and Newman W. G. (20110321). Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. : Breast cancer research and treatment.

MLA

Thompson Alastair M, Johnson Andrea, Quinlan Philip, Hillman Grantland, Fontecha Marcel, Bray Susan E, Purdie Colin A, Jordan Lee B, Ferraldeschi Roberta, Latif Ayshe, Hadfield Kirsten D, Clarke Robert B, Ashcroft Linda, Evans D Gareth, Howell Anthony, Nikoloff Michele, Lawrence Jeffrey and Newman William G. Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. : Breast cancer research and treatment. 20110321.